NATASHA ARUNDATHIE VEDAGE
Allopathic & Osteopathic Physicians|Internal Medicine PHILADELPHIA, PA NPI 1902255755
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine PA Abbott Laboratories All categories
General Payments — all program years on this page
$17,590.24
- Category: General Payments
- Program years: PY2021–2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $13,162.15 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $12,708.33 | 4 |
| Food and Beverage | $363.47 | 4 |
| Education | $90.35 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $7,125.00 | 2 |
| Medtronic, Inc. | $3,173.68 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $2,500.00 | 1 |
| Biosense Webster, Inc. | $159.54 | 1 |
| BAXTER HEALTHCARE | $149.33 | 1 |
| Actelion Pharmaceuticals US, Inc. | $32.94 | 1 |
| Novo Nordisk AS | $21.66 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077714495 | Biosense Webster, Inc. | $159.54 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078909497 | Actelion Pharmaceuticals US, Inc. | $32.94 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092326224 | Boston Scientific Corporation | $2,500.00 | 10/10/2024 | Grant | Undisputed | 01/23/2026 | View at CMS |
| 1097407371 | Novo Nordisk Inc | $21.66 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1112070068 | Medtronic, Inc. | $3,083.33 | 07/15/2024 | Grant | Undisputed | 01/23/2026 | View at CMS |
| 1112073077 | Medtronic, Inc. | $90.35 | 12/30/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1120657863 | Baxter Healthcare | $149.33 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124786142 | Abbott Laboratories | $3,750.00 | 08/26/2024 | Grant | Undisputed | 01/23/2026 | View at CMS |
| 1124786506 | Abbott Laboratories | $3,375.00 | 08/26/2024 | Grant | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.